• How are step therapy protocols adapting to new obesity meds?
• What clinical guidelines inform PA criteria?
• How are automated appeals reducing provider burden?
• What cost-effectiveness thresholds apply to GLP-1 drugs?
• How do coverage gaps impact adherence?
• What outcomes tracking validates PA decisions?
• How are formularies tiering obesity medications?
• What role do PAAS vendors play in processing?
• How are patient advocacy groups challenging denials?
• What AI tools predict approval likelihood?
• How do EU/US PA approaches differ?
• What lessons come from diabetes PA processes?

• PA
• Step Therapy
• Appeals Process
• Cost-Effectiveness
• Clinical Guidelines
• Patient Advocacy
• Automation
• Provider Burden
• Coverage Gaps
• Outcomes Tracking
• Formulary Tiers
• PAAS Vendors

• Request a Customized Transcript: Submit your own questions or specify changes. We’ll conduct a new call with the industry expert, covering both the original and your additional questions. You’ll receive an updated report for a small fee over the standard price.
• Request a Direct Call with the Expert: If you prefer a live conversation, we can facilitate a call between you and the expert. After the call, you’ll get the full recording, a verbatim transcript, and continued platform access to query the content and more.

‍